The ACSMEDI|EFMC Medicinal Chemistry Frontiers is co-organised as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal chemistry and Chemical biology).
The Programme will include:
This meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. The ACSMEDI|EFMC Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. The scientific programme for this meeting will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.
We look forward meeting you in Boston!
The Organising Committee